1. Home
  2. HOV vs ARVN Comparison

HOV vs ARVN Comparison

Compare HOV & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hovnanian Enterprises Inc.

HOV

Hovnanian Enterprises Inc.

HOLD

Current Price

$100.33

Market Cap

646.9M

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$10.76

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOV
ARVN
Founded
1959
2015
Country
United States
United States
Employees
1891
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
646.9M
658.2M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
HOV
ARVN
Price
$100.33
$10.76
Analyst Decision
Sell
Buy
Analyst Count
2
19
Target Price
$97.00
$15.05
AVG Volume (30 Days)
91.0K
651.5K
Earning Date
05-19-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.84
EPS
N/A
N/A
Revenue
N/A
$262,600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.96
N/A
P/E Ratio
$17.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$85.69
$5.90
52 Week High
$162.06
$14.22

Technical Indicators

Market Signals
Indicator
HOV
ARVN
Relative Strength Index (RSI) 35.90 49.58
Support Level $100.24 $9.02
Resistance Level $113.60 $12.43
Average True Range (ATR) 5.82 0.51
MACD -1.20 0.04
Stochastic Oscillator 4.68 61.68

Price Performance

Historical Comparison
HOV
ARVN

About HOV Hovnanian Enterprises Inc.

Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: